Abstract
Background
Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) have recently been suggested as diagnostic criteria for periprosthetic joint infection (PJI) diagnosis. Thresholds for these markers should be reexamined since they have been determined arbitrarily.
Questions/purposes
Based on recently defined criteria for PJI, we determined (1) whether there is a difference in the threshold value of ESR and CRP between hips and knees, (2) whether the threshold value for ESR and CRP should be different for early-postoperative and late-chronic PJI, and (3) the optimal thresholds for ESR and CRP in PJI diagnosis.
Methods
We retrospectively reviewed 1962 patients with revision arthroplasty for aseptic failure (1095 hips, 594 knees) or first onset of PJI (108 hips, 165 knees) between 2000 and 2009. The PJI diagnosis was made independent of ESR and CRP using criteria recently proposed by the Musculoskeletal Infection Society. Patients with comorbidities that confound ESR and CRP were not included. Receiver operating characteristic (ROC) analysis was performed to determine thresholds.
Results
ESR and CRP levels in late-chronic PJI were higher in knees than in hips. Optimal thresholds for ESR and CRP were 48.5 mm/hour and 13.5 mg/L in hips and 46.5 mm/hour and 23.5 mg/L in knees, respectively. In early-postoperative PJI, ESR and CRP were similar in both joints with common thresholds of 54.5 mm/hour and 23.5 mg/L, respectively.
Conclusions
The data suggest a similar threshold for ESR but not for CRP should be implemented for late-chronic hips and knees. Optimal magnitudes are higher than conventional thresholds, indicating the need for refinement of thresholds if ESR and CRP are to be criteria for PJI diagnosis. Early-postoperative and late-chronic PJI might require different thresholds.
Level of Evidence
Level III, diagnostic study. See Instructions for Authors for a complete description of levels of evidence.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Preoperative diagnosis of periprosthetic joint infection (PJI) is a challenging yet critical task [42]. The distinction between failures occurring as a result of infection and aseptic etiologies is an important requisite for delivery of appropriate surgical care [28].
Lack of a uniform and standard definition for PJI makes investigations difficult to compare [3]. The criterion of a minimum of two positive cultures of periprosthetic tissue material has been the most common definition in previous studies [29]. However, microbiologic cultures are not always successful in isolating the infecting organisms and contamination of samples may result in false-positive results [6]. Some authors have suggested different adjunctive criteria [5, 27, 36, 38] to overcome shortcomings of bacteriologic culture, leading to discrepancy in their inclusion and exclusion criteria. To resolve this inconsistency, an expert panel from the Musculoskeletal Infection Society (MSIS) has reviewed existing evidence and published a set of diagnostic criteria for PJI [30]. This new definition integrates clinical, serologic, microbiologic, and histopathologic findings and joint aspirate analysis to distinguish between infected and aseptic failures.
The introduction of erythrocyte sedimentation rate (ESR) and 12 Creactive protein (CRP) as criteria for diagnosis of PJI emphasizes the need for precise definition of their thresholds. Despite a considerable volume of literature, the appropriate thresholds are still unclear. Thresholds of 12 to 40 mm/hour for ESR and 3 to 13.5 mg/L for CRP have been proposed, with no distinction being made between PJI occurring in knees versus hips or late versus early infection [4]. This wide range of thresholds makes use of ESR and CRP confusing for PJI diagnosis at least for the purpose of uniform research. The MSIS suggests the conventional thresholds of 30 mm/hour and 10 mg/L for ESR and CRP, respectively, which were selected arbitrarily due to lack of studies determining the threshold [4, 9, 20, 24, 34, 36].
An important yet unaddressed question is whether thresholds of ESR and CRP for hips and knees should be similar. Based on receiver operating characteristics (ROC) analysis, some investigations have suggested thresholds for ESR and CRP, evaluating hips and knees separately or in combination [8, 10, 13, 14, 35]. However, they did not compare the mean or median values of ESR and CRP between infected prosthetic hips and knees. Therefore, these investigations have never examined whether any difference should exist between hips and knees in ESR and CRP thresholds for diagnosing PJI. They consistently reported thresholds higher than the conventional threshold for CRP, but their proposed magnitudes for ESR were less consistent and were slightly higher [8, 10, 13] and lower [14, 35] than the conventional threshold.
Even after uncomplicated arthroplasty, ESR and CRP remain elevated for 3 to 8 weeks [7, 14, 21, 26]. Thus, time after index arthroplasty can have a confounding influence on ESR and CRP values. This may hinder interpretation of the results of ESR and CRP in the early-postoperative setting, implying different thresholds might be required for early-postoperative and late-chronic PJIs.
We therefore determined (1) whether there is a difference in the threshold value of ESR and CRP between hips and knees, (2) whether the threshold value for ESR and CRP should be different for early-postoperative and late-chronic PJI, and (3) the optimal thresholds for ESR and CRP in diagnosis of PJI.
Patients and Methods
After obtaining institutional review board approval, we used the institutional computerized infection database to identify 2203 patients who underwent revision arthroplasty at our institution between 2000 and 2009 and had adequate preoperative workup to confirm or refute PJI (Fig. 1). Medical records were reviewed to retrieve demographic details and associated comorbidities. We excluded 180 patients for the following reasons: (1) comorbid conditions with confounding effects on ESR and CRP (eg, inflammatory autoimmune disorders, malignancies, organ failure [kidney, liver, heart], or preexisting infectious diseases [12, 25]) and (2) revision surgeries indicated for periprosthetic or component fractures. Our aseptic cohort consisted of 1095 patients in the hip group and 594 patients in the knee group. Based on the MSIS criteria, our periodically updated retrospective infection database was accessed to identify our septic cohort, which comprised 108 patients with hip PJI and 165 patients with knee PJI. Briefly, the MSIS suggested two major and six minor criteria for PJI. Major criteria, with each being indicative of PJI, included presence of a draining sinus and isolation of a pathogen from two separate tissue or fluid cultures. The presence of at least four of six minor criteria was also proposed to suggest PJI. The six minor criteria proposed were elevated ESR and CRP, elevated synovial white blood cell (WBC) count, increased synovial fluid polymorphonuclear cell percentage, isolation of a pathogen from one culture only, presence of purulence, and positive microscopy of the frozen section of periprosthetic tissue samples [30]. We do not routinely utilize frozen section of the periarticular tissues, thus eliminating one of the six minor criteria proposed by the MSIS. Since the aim of this study was to determine optimal cutoff values of ESR and CRP for diagnosing PJI, we excluded elevated ESR and CRP as a minor criterion and considered patients as having PJI if they had all of the remaining four minor criteria. Sixty-one patients from the original cohort were disqualified for this study since their PJI could not be established independently from ESR and CRP levels according to the MSIS criteria. The patients included in the PJI cohort fulfilled the diagnostic criteria as follows. Among hips, of the 108 patients, 24 (22%) had draining sinuses, 94 (87%) had at least two positive cultures, and 20 (19%) had four minor criteria (Fig. 2A). Among knees, of the 165 patients, 21 (13%) presented with draining sinuses, 144 (87%) were diagnosed by at least two positive cultures, and 101 (61%) met four minor criteria (Fig. 2B).
The mean age of the patients in the PJI cohort was 67 years (range, 40–93 years) in the hip arthroplasty group and 68 years (range, 37–90 years) in the knee arthroplasty group. Patients with aseptic hip revisions were 65 years old on average (range, 26–96 years) while those with aseptic knee revisions were 65 years old on average (range, 28–89 years). Women constituted 56% and 48% of the aseptic and septic hip revision groups, respectively, and 61% and 47% of aseptic and septic knee revision groups, respectively.
During revision arthroplasty, three to five samples of periprosthetic fluid or tissue material from the prosthesis-bone interface were sent for culture. Samples from the draining sinus were not included. Isolates were considered significant if they grew on solid agar or when an indistinguishable strain grew on enrichment medium more than once. Prophylactic intraoperative antibiotics were administered after sample extraction for all patients except those in whom infection was suspected but no organism had been isolated. Gram-positive bacteria were the responsible pathogens in the majority of PJIs (65% in hips, 58% in knees). Staphylococcus aureus was encountered as the most common organism in hips and knees, although in knees it was closely followed by coagulase-negative staphylococci (Table 1).
Before revision arthroplasty, we routinely obtain ESR and CRP and aspirate the joint in patients with abnormal serology and/or high index of suspicion for PJI (ie, painful prosthetic joint in the context of predisposing risk factors, constitutional symptoms, or clinical signs of PJI). We included the ESR and CRP values within 1 month before revision surgery. In case of multiple measurements, the values closest to the date of surgery were accepted. The laboratories of our institution utilize the semiautomated method for measurement of ESR. Immediately after extraction, samples were transferred to vacuum tubes containing prefilled sodium citrate and mixed by a special mixer (ESR-657; Streck, Omaha, NE, USA). An automated analyzer (ESR-Auto Plus®; Streck) measured ESR by using the QuickMode method. In this method, an infrared scanner measured red blood cell sedimentation level after 30 minutes on two scans (forward and backward); these values were then converted to an equivalent Westergren results in millimeter per hour using a mathematical formula. The turbidimetric method was utilized to measure CRP levels (Beckman Coulter Inc, Brea, CA, USA). Synovial WBC count and differential were measured using automated analyzers (Sysmex XE5000; Sysmex, Mundelein, IL, USA). In the PJI group, ESR and CRP values were missing in two patients (one hip and one knee) and two patients (two hips), respectively. ESR and CRP values were higher in the PJI groups than in the corresponding aseptic groups in both joints (Table 2).
To control for the confounding effect of the time factor, we classified the patients into early-postoperative PJI if infection occurred within 4 weeks of the index arthroplasty (42 hips, 42 knees). This time frame is arbitrary but is clinically practical. It allows for making decisions since prosthesis salvage has a favorable prognosis in the early-postoperative period [39]. The rest of the patients with PJI were categorized as late chronic (57 hips, 119 knees) except for nine hips and four knees for which previous surgery dates could not be verified and therefore were excluded from this subgroup analysis (Fig. 1).
We first compared hips and knees and then analyzed them separately and in combination. ESR and CRP were compared between septic and aseptic groups using a nonparametric Wilcoxon rank-sum test, setting alpha error at 0.05 as significant. The Kolmogorov-Smirnov test was used to compare the distribution pattern of ESR and CRP values between aseptic hip and knee revisions. We calculated routine characteristics of the diagnostic tests, including true-positive rate (sensitivity), true-negative rate (specificity), false-negative rate (1 − sensitivity), false-positive rate (1 − specificity), positive predictive value (PPV) (the probability of PJI when the test result is positive), negative predictive value (NPV) (the probability of not being PJI when the test result is negative), and the positive and negative likelihood ratios (LR+ and LR−), by constructing 2 × 2 tables for ESR and CRP separately in hips and knees. LR+ (sensitivity divided by 1 − specificity) and LR− (1 − sensitivity divided by specificity) are the proportion of patients with PJI with positive and negative test results to patients without PJI with positive and negative test results, respectively. ROC curves were subsequently constructed by mapping true-positive rate (sensitivity) against false-positive rate (1 − specificity) for each test-joint combination. The ROC curve is a graphical statistical tool that illustrates the discriminative effectiveness for a diagnostic test [31]. It shows how the trade-off between sensitivity and specificity occurs when different cutoff thresholds are examined consecutively. Better performing tests demonstrate larger areas under the curve (AUCs) and are plotted farther from the diagonal line of indiscrimination. The optimal cutoff value is the threshold by which the test can best classify a maximum number of cases as true positive and true negative and was calculated by Youden’s index (J) [31]. This index is a function of both sensitivity and specificity and finds where the sum of them is largest. Graphically, it is a point at the shoulder of the ROC curve, closest to the point of x = 0, y = 1 (ideal point with sensitivity and specificity of 100%) or farthest from the diagonal line of nondiscrimination. Subgroup analysis was also performed within each test-joint combination between early-postoperative and late-chronic cohorts using a Wilcoxon rank-sum test. Separate ROC curves were mapped only for those subgroups with significant differences. We performed the statistical analyses using SAS® statistical software (SAS Institute Inc, Cary, NC, USA).
Results
ESR values were not different (p = 0.31) between hip and knee PJI groups (median: 83 and 84 mm/hour, respectively). Likewise, ESR values were not different (p = 0.29) between aseptic hip and knee revisions (median: 19 and 20 mm/hour, respectively; mean: 24 and 26 mm/hour, respectively). Using the Kolmogorov-Smirnov test, there was no difference in the distribution of ESR values between aseptic groups (p = 0.49). CRP values were different (p = 0.02) between hip and knee PJI groups, with median values of 73 and 133 mg/L for hips and knees, respectively. Median CRP for aseptic hip and knee groups were different, at 6 and 7 mg/L, respectively (p < 0.001).
Subgroup analysis comparing early-postoperative hip with early-postoperative knee PJI revealed no difference for ESR and CRP. However, ESR and CRP values were both higher in late-chronic knees than in late-chronic hips (p = 0.005 and p < 0.001, respectively). Therefore, separate ROC analysis was performed for late-chronic hip and knee PJIs while sole ROC analysis was done combining patients with early-postoperative hip and knee PJI.
We also compared early-postoperative and late-chronic PJIs in each joint. A difference was detected for CRP in hips and for ESR in knees (p < 0.001 and p = 0.012, respectively). Median values for CRP in early-postoperative and late-chronic hips were 143 mg/L (interquartile range: 75–255 mg/L) and 56 mg/L (interquartile range: 21–85 mg/L), respectively. Median values for ESR in early-postoperative and late-chronic knees were 78 mm/hour (interquartile range: 44–91 mm/hour) and 90 mm/hour (interquartile range: 61–104 mm/hour), respectively.
For ESR in late-chronic PJI, ROC analysis yielded optimal magnitude of 48.5 and 46.5 mm/hour for hip and knee, respectively, which are similar yet higher than the conventional threshold of 30 mm/hour. For CRP in late-chronic PJI, optimal thresholds were consistently higher than the commonly used threshold of 10 mg/L. ROC plots established cutoff points of 13.5 and 23.5 mg/L for hips and knees, respectively. For early-postoperative PJI, common thresholds for ESR and CRP were calculated as 54.5 mm/hour and 23.5 mg/L, respectively (Fig. 3).
Comparison of the test characteristics between conventional (Table 3) and optimal (Table 4) thresholds for ESR and CRP consistently demonstrated improved specificity, PPV, and LR+ at the expense of slight worsening of sensitivity and LR−, while NPV remained practically unchanged. In both joints, the combination battery of ESR and CRP with new optimal magnitudes revealed improved specificity, PPV, and LR+ at the expense of worsening of sensitivity and LR− and with NPV unchanged between 97% and 98%.
Discussion
Until recently, a consistent and uniform definition for PJI did not exist [29]. The variation in PJI definition has resulted in uncertain conclusions from the existing evidence. The introduction of the MSIS criteria was an important step toward uniform research regarding PJI [30]. However, regardless of the diagnostic criteria, measurement of ESR and CRP has been deemed an important part of the workup of patients suspected of PJI [42]. These valuable markers can be performed rapidly, inexpensively, and with minimal inconvenience. However, they are nonspecific inflammatory markers and their measurement is affected by innumerable factors, including demographics (age and sex), underlying diseases, medications, severity and stage of inflammation, and other unknown factors [12, 25, 32, 36, 37, 41]. Therefore, it seems to be impossible to convert these quantitative tests into absolute binary systems (ie, infected versus noninfected). Nevertheless, strategies such as combination testing and ROC analysis can improve their performance as diagnostic armamentarium in PJI. We therefore determined (1) whether there is a difference in the threshold value of ESR and CRP between hips and knees, (2) whether the threshold value for ESR and CRP should be different for early-postoperative and late-chronic PJI, and (3) the optimal thresholds for ESR and CRP in diagnosis of PJI.
We recognize some limitations to our investigation. First, due to the retrospective nature of the study, adequate data for confidently distinguishing between acute hematogenous and late-chronic PJI were unavailable. Clinical distinction between these two conditions is not obvious and requires rigorous criteria to rule out hematogenous spread of a primary source of infection to a prosthetic joint. Moreover, perioperatively acquired infections can remain silent for several months up to 2 years [33]. This could have distorted our subgroup analysis compared to isolated grouping that could have consisted of patients with early-postoperative, late-chronic, and acute hematogenous PJI. Second, in our institution, histologic analysis of intraoperative specimens is not performed; therefore, of the six minor criteria, only five were available for this study and elevated ESR and CRP was eliminated as a criterion since we were studying those parameters, which left only four. Moreover, joint aspiration was performed on the basis of the treating surgeon’s discretion and was not routinely performed for every patient with PJI. If these data had been available, we would have excluded fewer than 61 patients (14 hips) from our infection database. However, our relatively large study size permits us to be confident regarding our results. Third, many factors affect the level of inflammatory markers. This may cause some uncertainty regarding how the constellation of unknown and known factors could have biased our results. Finally, other useful diagnostic modalities, such as leukocyte esterase, IL-6, sonication of explanted prosthesis, and PCR, remain potential diagnostic tools for PJI [4, 11, 22, 28, 30, 38]. Therefore, the MSIS definition can be subject to future modifications, as are the thresholds for any criteria within new combinational algorithms. ESR and CRP are not exempted from this process.
Based on our findings, ESR and CRP levels were higher in knee PJIs than in hip PJIs. This fact was reflected in the comparison between late-chronic PJIs. Nevertheless, it seems index surgery conceals this difference in the early-postoperative period. For hips, CRP levels were higher in early-postoperative PJI than in late-chronic PJI, while for knees this difference was not detected. Moreover, ESR levels were unexpectedly slightly higher in late-chronic knee PJIs. It is possible some unrecognized acute hematogenous PJI cases could have skewed ESR levels in our late-chronic knee PJI subgroup.
This study suggests optimal thresholds for CRP should be different for late-chronic PJI in hips and knees (13.5 and 23.5 mg/L, respectively). This finding is additive to the existing evidence and may reflect the normal physiologic difference of inflammatory reaction to arthroplasty that is more intense in knees than in hips [7, 21, 24, 40]. The exact mechanism remains unknown, though Larsson et al. [21] suggested TKA is more traumatic to bone and marrow tissue, which has a higher content of inflammatory cells. Although ESR values were higher in late-chronic knees than in hips, thresholds were calculated at approximately similar points (48.5 and 46.5 mm/hour for hips and knees, respectively). We suggest similar thresholds for the two joints in the early postoperative period (54.5 mm/hour for ESR and 23.5 mg/L for CRP, respectively). However, pathophysiologic differences in ESR and CRP should also be considered. Two studies [21, 26] have shown, after arthroplasty, ESR increases more slowly and less prominently than CRP. It also decreases more slowly, reacts less consistently, and may have more frequent atypical patterns than CRP. Studies evaluating postoperative trends of these markers agree CRP is a more reliable indicator for detecting early-postoperative PJI [1, 19, 23, 24, 26, 34].
Our suggested cutoff values for ESR and CRP were uniformly higher than the conventional thresholds. Regarding CRP, this is relatively concordant with most previous studies (Table 5). However, our proposed threshold for ESR is higher than the conventional magnitude and is not consistent with the same studies reporting thresholds lower [14, 35] or slightly higher [8, 10, 13] than the conventional threshold. This discrepancy could be due to several reasons. Although relatively similar criteria were used for PJI, the value attributed to components, such as major or minor criteria, was not similar. Moreover, the factor of time after index surgery (early-postoperative versus late-chronic) was not taken into account in those studies. Finally, technical details, such as type of anticoagulant, type of collection tube (simple versus vacuum), mixture technique of sample with anticoagulants, and measuring method (manual versus automated), can potentially affect ESR measurements. The International Council for Standardization in Haematology [18] has published recommendations as reference for ESR measurement. Nevertheless, several studies [2, 15–17] have reported discordance between the traditional Westergren method and modern automated analyzers and even among different automated analyzers. Technical details of ESR and CRP measurement were not provided in previous studies [8, 10, 13, 14, 35]. We have been using a semiautomated method for ESR measurement in our institution and wonder how technical issues could have contributed to this inconsistency.
In conclusion, it seems a similar threshold for ESR (that is higher than the conventional threshold) should be applied for PJI diagnosis in hips and knees. The optimal threshold for CRP seems to be higher than conventional thresholds, but magnitudes for hips and knees should be different. Moreover, different thresholds should be implemented for CRP in the early-postoperative and late-chronic PJI settings, at least for hips, while ESR thresholds are probably similar in both conditions. Conventional thresholds for these inflammatory markers are useful for screening of individual patients. However, they need to be refined to improve accuracy of this test battery as a diagnostic criterion for PJI.
References
Aalto K, Osterman K, Peltola H, Räsänen J. Changes in erythrocyte sedimentation rate and C-reactive protein after total hip arthroplasty. Clin Orthop Relat Res. 1984;184:118–120.
AlFadhli SM, Al-Awadhi AM. Comparison of erythrocyte sedimentation rate measurement by the automated SEDIsystem and conventional Westergren method using the Bland and Altman statistical method. Med Princ Pract. 2005;14:241–244.
Bauer TW, Parvizi J, Kobayashi N, Krebs V. Diagnosis of periprosthetic infection. J Bone Joint Surg Am. 2006;88:869–882.
Berbari E, Mabry T, Tsaras G, Spangehl M, Erwin PJ, Murad MH, Steckelberg J, Osmon D. Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am. 2010;92:2102–2109.
Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen WS, Osmon DR. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998;27:1247–1254.
Berbari EF, Marculescu C, Sia I, Lahr BD, Hanssen AD, Steckelberg JM, Gullerud R, Osmon DR. Culture-negative prosthetic joint infection. Clin Infect Dis. 2007;45:1113–1119.
Bilgen O, Atici T, Durak K, Karaeminoğullari O, Bilgen MS. C-reactive protein values and erythrocyte sedimentation rates after total hip and total knee arthroplasty. J Int Med Res. 2001;29:7–12.
Bottner F, Wegner A, Winkelmann W, Becker K, Erren M, Götze C. Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg Br. 2007;89:94–99.
Carlsson AS. Erythrocyte sedimentation rate in infected and non-infected total-hip arthroplasties. Acta Orthop Scand. 1978;49:287–290.
Cipriano CA, Brown NM, Michael AM, Moric M, Sporer SM, Della Valle CJ. Serum and synovial fluid analysis for diagnosing chronic periprosthetic infection in patients with inflammatory arthritis. J Bone Joint Surg Am. 2012;94:594–600.
Di Cesare PE, Chang E, Preston CF, Liu C. Serum interleukin-6 as a marker of periprosthetic infection following total hip and knee arthroplasty. J Bone Joint Surg Am. 2005;87:1921–1927.
Du Clos TW, Mold C. C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunol Res. 2004;30:261–277.
Ghanem E, Antoci V, Pulido L, Joshi A, Hozack W, Parvizi J. The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty. Int J Infect Dis. 2009;13:e444–e449.
Greidanus NV, Masri BA, Garbuz DS, Wilson SD, McAlinden MG, Xu M, Duncan CP. Use of erythrocyte sedimentation rate and C-reactive protein level to diagnose infection before revision total knee arthroplasty: a prospective evaluation. J Bone Joint Surg Am. 2007;89:1409–1416.
Hardeman MR, Levitus M, Pelliccia A, Bouman AA. Test 1 analyser for determination of ESR. 1. Practical evaluation and comparison with the Westergren technique. Scand J Clin Lab Invest. 2010;70:21–25.
Horsti J. EDTA samples for the measurement of erythrocyte sedimentation rate using Sedimatic 100 analyser. Clin Chem Lab Med. 2001;39:1001–1003.
Horsti J, Rontu R, Collings A. A comparison between the StaRRsed Auto-Compact Erythrocyte Sedimentation Rate Instrument and the Westergren method. J Clin Med Res. 2010;2:261–265.
International Council for Standardization in Haematology. ICSH recommendations for measurement of erythrocyte sedimentation rate. International Council for Standardization in Haematology (Expert Panel on Blood Rheology). J Clin Pathol. 1993;46:198–203.
Kolstad K, Levander H. Inflammatory laboratory tests after joint replacement surgery. Ups J Med Sci. 1995;100:243–248.
Lachiewicz PF, Rogers GD, Thomason HC. Aspiration of the hip joint before revision total hip arthroplasty: clinical and laboratory factors influencing attainment of a positive culture. J Bone Joint Surg Am. 1996;78:749–754.
Larsson S, Thelander U, Friberg S. C-reactive protein (CRP) levels after elective orthopedic surgery. Clin Orthop Relat Res. 1992;275:237–242.
Mariani BD, Martin DS, Levine MJ, Booth RE Jr, Tuan RS. The Coventry Award. Polymerase chain reaction detection of bacterial infection in total knee arthroplasty. Clin Orthop Relat Res. 1996;331:11–22.
Moreschini O, Greggi G, Giordano MC, Nocente M, Margheritini F. Postoperative physiopathological analysis of inflammatory parameters in patients undergoing hip or knee arthroplasty. Int J Tissue React. 2001;23:151–154.
Niskanen RO, Korkala O, Pammo H. Serum C-reactive protein levels after total hip and knee arthroplasty. J Bone Joint Surg Br. 1996;78:431–433.
Olshaker JS, Jerrard DA. The erythrocyte sedimentation rate. J Emerg Med. 1997;15:869–874.
Park KK, Kim TK, Chang CB, Yoon SW, Park KU. Normative temporal values of CRP and ESR in unilateral and staged bilateral TKA. Clin Orthop Relat Res. 2008;466:179–188.
Parvizi J, Ghanem E, Sharkey P, Aggarwal A, Burnett RS, Barrack RL. Diagnosis of infected total knee: findings of a multicenter database. Clin Orthop Relat Res. 2008;466:2628–2633.
Parvizi J, Jacovides C, Antoci V, Ghanem E. Diagnosis of periprosthetic joint infection: the utility of a simple yet unappreciated enzyme. J Bone Joint Surg Am. 2011;93:2242–2248.
Parvizi J, Jacovides C, Zmistowski B, Jung KA. Definition of periprosthetic joint infection: is there a consensus? Clin Orthop Relat Res. 2011;469:3022–3030.
Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011;469:2992–2994.
Perkins NJ, Schisterman EF. The Youden Index and the optimal cut-point corrected for measurement error. Biomed J. 2005;47:428–441.
Saadeh C. The erythrocyte sedimentation rate: old and new clinical applications. South Med J. 1998;91:220–225.
Sendi P, Zimmerli W. Challenges in periprosthetic knee-joint infection. Int J Artif Organs. 2011;34:947–956.
Shih LY, Wu JJ, Yang DJ. Erythrocyte sedimentation rate and C-reactive protein values in patients with total hip arthroplasty. Clin Orthop Relat Res. 1987;225:238–246.
Society of Unicondylar Research and Continuing Education. Diagnosis of periprosthetic joint infection after unicompartmental knee arthroplasty. J Arthroplasty. 2012;27(8 suppl):46–50.
Spangehl MJ, Masri BA, O’Connell JX, Duncan CP. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am. 1999;81:672–683.
Thue G, Sandberg S, Fugelli P. The erythrocyte sedimentation rate in general practice: clinical assessment based on case histories. Scand J Clin Lab Invest. 1994;54:291–300.
Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, Osmon DR, Mandrekar JN, Cockerill FR, Steckelberg JM, Greenleaf JF, Patel R. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med. 2007;357:654–663.
Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty: a study of the treatment of one hundred and six infections. J Bone Joint Surg Am. 1996;78:512–523.
White J, Kelly M, Dunsmuir R. C-reactive protein level after total hip and total knee replacement. J Bone Joint Surg Br. 1998;80:909–911.
Wolfe F, Michaud K. The clinical and research significance of the erythrocyte sedimentation rate. J Rheumatol. 1994;21:1227–1237.
Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645–1654.
Acknowledgments
The authors thank Mitchel Maltenfort PhD for his assistance in statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Additional information
One of the authors certifies that he (JP), or a member of his or her immediate family, has received or may receive payments or benefits, during the study period, an amount of less than USD 100,000 from Zimmer Inc (Warsaw, IN, USA), Smith & Nephew Inc (Memphis, TN, USA), ConvaTec (Princeton, NJ, USA), 3 M (Minneapolis, MN, USA), and TissueGene Inc (Baltimore, MD, USA).
All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research editors and board members are on file with the publication and can be viewed on request.
Each author certifies that his or her institution approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.
About this article
Cite this article
Alijanipour, P., Bakhshi, H. & Parvizi, J. Diagnosis of Periprosthetic Joint Infection: The Threshold for Serological Markers. Clin Orthop Relat Res 471, 3186–3195 (2013). https://doi.org/10.1007/s11999-013-3070-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11999-013-3070-z